Validation of candidate driver genes POT1 and ATM. Schematics of each protein are shown with the locations of mutations identified (top). Sanger validation of SNVs in lesional skin, diagnostic blood samples, and mRNA isolated from CD4⁺-enriched tumor cells (bottom).